Glaxosmithkline Pharmaceuticals Ltd Q2 FY2024-2025 Results: Summary
Revenue | ₹1,050Cr |
Net Profits | ₹252.50Cr |
Net Profit Margins | 24.05% |
Glaxosmithkline Pharmaceuticals Ltd’s revenue jumped 6.58% since last year same period to ₹1,050Cr in the Q2 2024-2025. On a quarterly growth basis, Glaxosmithkline Pharmaceuticals Ltd has generated 23.49% jump in its revenue since last 3-months.
Glaxosmithkline Pharmaceuticals Ltd’s net profit jumped 16.09% since last year same period to ₹252.50Cr in the Q2 2024-2025. On a quarterly growth basis, Glaxosmithkline Pharmaceuticals Ltd has generated 38.49% jump in its net profits since last 3-months.
Glaxosmithkline Pharmaceuticals Ltd’s net profit margin jumped 8.92% since last year same period to 24.05% in the Q2 2024-2025. On a quarterly growth basis, Glaxosmithkline Pharmaceuticals Ltd has generated 12.15% jump in its net profit margins since last 3-months.
